These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3415603)

  • 41. Refining the prognostic significance of DNA ploidy status in colorectal cancer: a prospective flow cytometric study.
    Jones DJ; Moore M; Schofield PF
    Int J Cancer; 1988 Feb; 41(2):206-10. PubMed ID: 3338871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flow cytometric analysis of DNA content and cell kinetics in colorectal carcinoma.
    D'Agnano I; Cosimelli M; La Pera A; Cavaliere F; Mannella E; Giannarelli D; Cavaliere R; Zupi G
    Anticancer Res; 1993; 13(3):699-703. PubMed ID: 8317899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of needle aspiration and solid biopsy technics in the flow cytometric study of DNA distributions of surgically resected tumors.
    Greenebaum E; Koss LG; Sherman AB; Elequin F
    Am J Clin Pathol; 1984 Nov; 82(5):559-64. PubMed ID: 6496402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.
    Buglioni S; D'Agnano I; Cosimelli M; Vasselli S; D'Angelo C; Tedesco M; Zupi G; Mottolese M
    Int J Cancer; 1999 Dec; 84(6):545-52. PubMed ID: 10567896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Classification and prognosis of colorectal cancers. Evaluation with multiparameter flow cytometry].
    Wirsching R; Valet G; Wiebecke B
    Fortschr Med; 1985 Jun; 103(21):584-7. PubMed ID: 4018686
    [No Abstract]   [Full Text] [Related]  

  • 47. [Flow cytometric analysis of colorectal cancer and polyps].
    Wang LP
    Zhonghua Bing Li Xue Za Zhi; 1992 Feb; 21(1):47-9. PubMed ID: 1319849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Are there markers for the risk of colorectal cancer?
    Sherlock P; Winawer SJ
    N Engl J Med; 1984 Jul; 311(2):118-9. PubMed ID: 6738589
    [No Abstract]   [Full Text] [Related]  

  • 49. Survival of large bowel carcinoma patients with different DNA ploidy.
    Rognum TO; Thorud E; Lund E
    Br J Cancer; 1987 Nov; 56(5):633-6. PubMed ID: 3426928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Colorectal cancer: an new role for the anatomic pathologist].
    Scoazec JY
    Ann Pathol; 2000 Mar; 20(2):176-7. PubMed ID: 10740021
    [No Abstract]   [Full Text] [Related]  

  • 51. [Colorectal neoplasms and heredity].
    Utsunomiya J
    Nihon Rinsho; 1981 May; 39(5):2052-60. PubMed ID: 7026832
    [No Abstract]   [Full Text] [Related]  

  • 52. Predictive assays for the therapy of rectal carcinoma.
    Streffer C; van Beuningen D; Mlynek ML; Gross E; Eigler FW
    Recent Results Cancer Res; 1988; 110():274-80. PubMed ID: 3406505
    [No Abstract]   [Full Text] [Related]  

  • 53. DNA ploidy of colorectal carcinoma by tumour site, gender and history of noncolorectal malignancies.
    Kouri M
    Oncology; 1993; 50(1):41-5. PubMed ID: 8421597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.
    Sidransky D; Tokino T; Hamilton SR; Kinzler KW; Levin B; Frost P; Vogelstein B
    Science; 1992 Apr; 256(5053):102-5. PubMed ID: 1566048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Genetic predisposition to colorectal cancer].
    Thomas G
    Ann Gastroenterol Hepatol (Paris); 1993 May; 29(3):123-4. PubMed ID: 8390798
    [No Abstract]   [Full Text] [Related]  

  • 56. Identification of colon cancer patients by molecular diagnosis.
    Müller O
    Dig Dis; 2003; 21(4):315-9. PubMed ID: 14752221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel.
    Ahlquist DA; Skoletsky JE; Boynton KA; Harrington JJ; Mahoney DW; Pierceall WE; Thibodeau SN; Shuber AP
    Gastroenterology; 2000 Nov; 119(5):1219-27. PubMed ID: 11054379
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic significance of ploidy determination in rectal cancer.
    Michelassi F; Ewing C; Montag A; Vannucci L; Segalin A; Panozzo M; Bibbo M; Dytch H; Chieco-Bianchi P
    Hepatogastroenterology; 1992 Jun; 39(3):222-5. PubMed ID: 1505893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of prognostic value of flow cytometric DNA content analysis in colorectal adenocarcinomas.
    Sciallero S; Bonelli L; Geido E; Lettieri L; Zeraschi E; Bruzzi P; Aste H; Giaretti W
    Eur J Cancer; 1994; 30A(4):569. PubMed ID: 8018423
    [No Abstract]   [Full Text] [Related]  

  • 60. Recent study on colorectal cancer in China: early detection and novel related gene.
    Zheng S
    Chin Med J (Engl); 1997 Apr; 110(4):309-10. PubMed ID: 9594234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.